Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Mirum Pharmaceuticals
12730 High Bluff Dr., #160
San Diego, CA 92130
https://mirumpharma.com/

Mirum Pharmaceuticals Inc. is a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions. The company's lead product candidate, maralixibat, is a Phase 3-ready investigational oral drug with an established safety profile and efficacy data in several indications, including Alagille syndrome (ALGS) and progressive familial intrahepatic cholestasis (PFIC).

Key Contact
Name
Mike Grey
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
11/07/18 $120,000,000 Series A Deerfield Management Company, L.P.
Frazier Healthcare
New Enterprise Associates
Novo
Pappas Capital
RiverVest Venture Partners
Rock Springs Capital
undisclosed


Featured Reading